India and Liberia Sign MoU to Boost Cooperation on Medicine Quality Standards

India and Liberia have taken a significant step toward strengthening global health collaboration by signing a Memorandum of Understanding (MoU) aimed at enhancing cooperation in the field of pharmacopoeia. The agreement focuses on developing shared medicine quality standards, improving regulatory alignment, and expanding access to safe, effective and affordable medicines.

The MoU was signed in Monrovia by India’s Ambassador Manoj Bihari Verma and Liberia’s Health Minister Dr. Louise M. Kpoto, marking an important milestone in India–Liberia bilateral health relations.

Purpose of the MoU: Strengthening Medicine Quality Standards

According to the Ministry of Health, the MoU aims to:

• Promote shared pharmacopoeial standards
• Improve regulatory collaboration between India and Liberia
• Support access to safe and affordable medicines
• Contribute to broader global health cooperation efforts

The move aligns with India’s commitment to helping partner nations build stronger, more reliable public health systems, especially in the developing world.

Liberia to Use the Indian Pharmacopoeia

The Embassy of India in Monrovia highlighted that the agreement enables Liberia to adopt the Indian Pharmacopoeia as a reference standard for medicine quality.

This will help Liberia:

• Strengthen its regulatory frameworks
• Improve medicine quality assessment
• Enhance access to safe and effective pharmaceuticals
• Build confidence in drug imports and domestic supply chains

The Indian Pharmacopoeia is widely recognized for its scientific rigor and comprehensive drug quality benchmarks, making it a valuable reference tool for emerging healthcare systems.

Why Pharmacopoeia Matters: Role Explained by Ministry of AYUSH

Pharmacopoeias are official compendia that define and standardize:

• Identity of drugs
• Purity levels
• Strength and potency
• Testing parameters and limits

The Indian Pharmacopoeia includes detailed monographs backed by modern analytical methods such as:

• High Performance Thin-Layer Chromatography (HPTLC)
• High Performance Liquid Chromatography (HPLC)
• Gas Chromatography (GC)
• UV-Visible Spectrophotometry
• Atomic Absorption Spectroscopy (AAS)
• Inductively Coupled Plasma methods (ICP-AES, ICP-MS)

It also sets crucial limits on:

• Heavy and toxic metals
• Pesticide residues
• Aflatoxins
• Microbial contamination

These standards help ensure that medicines are safe, reliable, and effective, making them essential for public health protection.

Significance of the India–Liberia Health Partnership

The MoU is expected to deliver long-term benefits for both countries:

For Liberia

• Stronger regulatory oversight
• Better access to quality-assured medicines
• Improved public health outcomes
• Enhanced capacity for pharmaceutical testing

For India

• Strengthened global influence in the pharmaceutical sector
• Expanded cooperation in Africa
• Promotion of Indian Pharmacopoeia as a global standard
• Contribution to global health equity

This collaboration also supports India’s vision of helping partner countries build capacity in medicine quality assurance, a growing need across Africa.